Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Avidence Therapeutics

Clinical trials sponsored by Avidence Therapeutics, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New knee shot targets arthritis pain in early trial Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New knee shot targets arthritis pain in early trial

Symptom relief Recruiting now

This early-stage study tests a single injection of AVD275, a new form of the pain reliever celecoxib, in 15 adults with knee osteoarthritis. The goal is to check safety and how the drug spreads in the body. Participants will be monitored for 24 weeks after the shot.

Phase 1 • Sponsor: Avidence Therapeutics • Aim: Symptom relief

Last updated Jun 27, 2026 12:02 UTC